ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,222.68
      0.00%
      US Tech 100
      17,750.00
      0.38%
      Dow Jones
      39,512.84
      0.00%
      Brent Oil
      82.995
      0.74%
      Bitcoin
      62,800.46
      2.20%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Axonics Inc (AXNX)

      7. Axonics Inc (AXNX) News

      AXNX

      Axonics (AXNX)

      Axonics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AXNX
      DateTimeSourceHeadlineSymbolCompany
      04/30/20244:01PMBusiness WireAxonics Reports First Quarter 2024 Financial ResultsNASDAQ:AXNXAxonics Inc
      04/24/20246:30AMPR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NASDAQ:AXNXAxonics Inc
      03/22/20244:01PMBusiness WireAxonics Stockholders Approve Merger Agreement with Boston ScientificNASDAQ:AXNXAxonics Inc
      03/21/20244:54PMBusiness WireAxonics Provides Update on Inter Partes Review ProceedingsNASDAQ:AXNXAxonics Inc
      03/14/20246:00AMBusiness WireAxonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemNASDAQ:AXNXAxonics Inc
      03/07/20245:24PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AXNXAxonics Inc
      02/29/20244:01PMBusiness WireAxonics Responds to ITC Action by MedtronicNASDAQ:AXNXAxonics Inc
      02/28/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
      02/28/20244:01PMBusiness WireAxonics Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:AXNXAxonics Inc
      02/22/20248:00AMEdgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AXNXAxonics Inc
      02/02/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
      02/02/20245:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
      02/02/20245:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
      02/02/20245:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
      01/31/20246:30AMPR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NASDAQ:AXNXAxonics Inc
      01/10/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
      01/10/20243:07PMPR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:AXNXAxonics Inc
      01/08/20245:19PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AXNXAxonics Inc
      01/08/20245:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
      01/08/20244:55PMPR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NASDAQ:AXNXAxonics Inc
      01/08/202411:36AMDow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNASDAQ:AXNXAxonics Inc
      01/08/20248:47AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
      01/08/20247:41AMDow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNASDAQ:AXNXAxonics Inc
      01/08/20247:00AMPR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NASDAQ:AXNXAxonics Inc
      01/08/20247:00AMBusiness WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNASDAQ:AXNXAxonics Inc
      01/08/20247:00AMBusiness WireAxonics Reports Preliminary 4Q23 and Fiscal Year 2023 RevenueNASDAQ:AXNXAxonics Inc
      12/28/20237:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
      12/27/20234:01PMBusiness WireAxonics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:AXNXAxonics Inc
      12/26/20231:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXNXAxonics Inc
      11/06/202312:00PMGlobeNewswire Inc.Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual DisabilitiesNASDAQ:AXNXAxonics Inc
       Showing the most relevant articles for your search:NASDAQ:AXNX